BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 17049184)

  • 1. Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Wang H; Li P; Zhang X; Xia Z; Lu Y; Huang H
    Oncol Lett; 2016 Aug; 12(2):825-836. PubMed ID: 27446357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
    Kim TH; Kim JS; Suh YG; Cho J; Yang WI; Suh CO
    Yonsei Med J; 2016 Jul; 57(4):846-54. PubMed ID: 27189276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.
    Yang Y; Zhang YJ; Zhu Y; Cao JZ; Yuan ZY; Xu LM; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Liu QF; Li YX
    Leukemia; 2015 Jul; 29(7):1571-7. PubMed ID: 25697894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression in lymphoma in north-west of iran.
    Sanaat Z; Tavangar SM; Gharamaleki JV; Kermani IA; Ziae JE; Nikanfar A; Esfahani A; Chavoshi SH; Bevrani H; Akbari F
    Int J Hematol Oncol Stem Cell Res; 2013; 7(1):1-4. PubMed ID: 24505512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.
    Nikolaos N; Grigorios P; Konstantinos K; Savvas T; Vassiliki Z; Alexandra S; Theodoros P
    Am J Case Rep; 2012; 13():79-85. PubMed ID: 23569495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type.
    Hong J; Park S; Baek HL; Jung JH; Kang IG; Sym SJ; Park J; Ahn JY; Cho EK; Kim ST; Shin DB; Lee JH
    Int J Clin Exp Pathol; 2012; 5(9):939-47. PubMed ID: 23119111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.
    Ma HH; Qian LT; Pan HF; Yang L; Zhang HY; Wang ZH; Ma J; Zhao YF; Gao J; Wu AD
    Med Oncol; 2010 Sep; 27(3):798-806. PubMed ID: 19685292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and cancer: how friendly is the relationship for cancer patients?
    Aggarwal BB; Gehlot P
    Curr Opin Pharmacol; 2009 Aug; 9(4):351-69. PubMed ID: 19665429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
    Bernard MP; Bancos S; Sime PJ; Phipps RP
    Curr Pharm Des; 2008; 14(21):2051-60. PubMed ID: 18691115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
    Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
    Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal midline granuloma-nasal natural killer/T-cell lymphoma.
    Mendenhall WM; Olivier KR; Lynch JW; Mendenhall NP
    Am J Clin Oncol; 2006 Apr; 29(2):202-6. PubMed ID: 16601443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
    Youssef YB; Bougmiza I; Bouabid Z; Achour B; Regaieg H; Sriha B; Belkadhi M; Omri HE; Khelif A
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):275-83. PubMed ID: 22991988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
    Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.
    Koom WS; Chung EJ; Yang WI; Shim SJ; Suh CO; Roh JK; Yoon JH; Kim GE
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1127-37. PubMed ID: 15234048
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.